Fundraising FoxIrving Investors
Crossover fundNew York · Growth–Late Stage · 8 people tracked
Find your way into Irving Investors
Sign up to see every warm intro you have to Irving Investors
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Irving Investors team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Irving Investors runs a sector-agnostic crossover strategy spanning public equities and late-stage private companies, applying a venture mindset to public market investing. It uses a single-name strategy to maximize alpha across the capital structure and pursues both disruptive and durable long-term opportunities. Beyond its founding focus on disruptive technology and high-growth situations, the firm has expanded into credit and private investments. Irving emphasizes building meaningful, supportive relationships with portfolio companies, offering capital, expertise, and connections to promote growth and returns, and has taken board seats in some holdings. It has participated in several private exits and acts as a trusted advisor and LP in venture capital funds.
Source: firm website, verified Sep 27, 2026.
Team · 8 people
from the firm's website
What they invest in
from 7 of 7 portfolio companiesBiotech ×6Deep Tech ×3AI & Machine Learning ×2Healthtech ×2Medical Devices ×2Cybersecurity ×1Developer Tools ×1Digital Health ×1
HQs:United States×5
Investments · 7 tracked
founders shown can be your intro pathBy year:2022 · 22021 · 42020 · 17 dated
Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.
BiotechBrookline, US
Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)
BoardGeorge M. Church(Director)
Co-investorsAlta PartnersARCH Venture PartnersCatalio Capital Management, LPHBM Healthcare InvestmentsHBM PartnersKhosla Ventures+12 more
A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.
BiotechHealthtech
Co-investorsFrazier Life SciencesHighlight CapitalMRL Ventures FundXeraya CapitalAmgen VenturesBlackRock+5 more
LUMICKS develops life science research tools that measure and apply forces around biological interactions to link structural and 'omics analysis to functional outcomes at the molecular and cellular level.
BiotechDeep TechHardwareMedical Devices
Andrea(Co-founder & Chief Scientific Officer)Gerrit(Co-founder & Director of Product Management and Marketing)Hugo(CEO)Edmee(Chief Financial Officer)Hannah(HR Director)
Co-investorsLauxera Capital PartnersSoftBank Vision FundEuropean Investment BankGilde HealthcarePura Vida InvestmentsT. Rowe Price
Metagenomi is a genetic medicines company developing therapies based on gene editing technologies to treat patients with serious diseases.
BiotechDeep TechHealthtechMedical DevicesBerkeley, US
Brian Thomas(Founder)inBrian Thomas Jillian Banfield(Founder)Jill Banfield(Founder)Jian Irish(President and CEO)
BoardAndrew Farquharson(Director)inJak Knowles(Director)
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalFrazier Life SciencesHumboldt+5 more
Model Medicines is an AI-powered biotechnology company that uses computation to discover and engineer small molecule drugs targeting disease-driving biological mechanisms.
AI & Machine LearningBiotechDeep TechDigital HealthLa Jolla, US
Daniel Haders(Founder)inDaniel Haders II, Ph.D(Founder, CEO)inSean Russell(Founder, Chief Operating Officer)inKip Quackenbush(Executive Officer, Director)inMarlon Evans(Executive Officer, Director)in
Snyk is a developer-focused security platform that identifies and fixes vulnerabilities in code, dependencies, containers, and cloud infrastructure using AI-powered analysis.
AI & Machine LearningCybersecurityDeveloper ToolsBoston, US
Guy Podjarny(Founder)inPeter McKay(Executive Officer, Director)inStephanie Dominy(Executive Officer)inAssaf Hefetz(Founder)Danny Grander(Founder)Peter McKay (CEO)(Founder)
Co-investors2050 CapitalAccelAlkeon InnovationAmity VenturesAmplify PartnersAtlassian Ventures+44 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 1
1 acquisitionsImagoacq. by Merck
Frequently asked questions
- How many investments has Irving Investors made?
- Irving Investors has 7 tracked investments, 1 of which have exited.
- What stage does Irving Investors invest at?
- Irving Investors invests at the Growth, Late Stage stages.
- What sectors does Irving Investors focus on?
- Irving Investors focuses on Deep Tech, Sector Agnostic.
- Where is Irving Investors located?
- Irving Investors is headquartered in New York, US.
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Founders Fund is a venture capital firm that backs technology companies building transformative products.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Inveready is a Spanish alternative investment firm founded in 2008, offering investment solutions and wealth management services across the small and mid-market segment in Spain.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.